Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (391-400 of 455) with videos related to

Pageof 46
Sort By:
Cardiovascular Diabetology|June 13, 2026
The effect of empagliflozin on inflammation in patients with overweight or obesity and risk of heart failure: a substudy from the Empire Prevent Metabolic trialCamilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
Endocrinology|March 30, 2022
Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2Stephanie Holm, Anna S Husted, Louise J Skov, et al.
Diabetes, Obesity & Metabolism|October 6, 2023
The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID-19 in the capital region of DenmarkVivian Kliim-Hansen, Karl S Johansson, Laerke S Gasbjerg, et al.
BMJ Open|January 31, 2023
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, et al.
European Journal of Endocrinology|April 22, 2021
Effects of endogenous GIP in patients with type 2 diabetesSigne Stensen, Lærke S Gasbjerg, Liva L Krogh, et al.
Annals of the Rheumatic Diseases|September 4, 2017
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studiesSabrina M Nielsen, Else M Bartels, Marius Henriksen, et al.
Diabetes Care|November 5, 2016
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist CircumferenceSigne Foghsgaard, Camilla Andreasen, Louise Vedtofte, et al.
Diabetologia|May 5, 2024
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank studyMarie Winther-Sørensen, Sara L Garcia, Andreas Bartholdy, et al.
Allergy|February 24, 2023
Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis-A randomized controlled studyLise Gether, Heidi Storgaard, Sanja Kezic, et al.
Diabetologia|September 29, 2017
Enteroendocrine K and L cells in healthy and type 2 diabetic individualsTina Jorsal, Nicolai A Rhee, Jens Pedersen, et al.
Pageof 46

Showing results (391-400 of 455) with videos related to

Sort By:
Pageof 46
Cardiovascular Diabetology|June 13, 2026
The effect of empagliflozin on inflammation in patients with overweight or obesity and risk of heart failure: a substudy from the Empire Prevent Metabolic trialCamilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
Endocrinology|March 30, 2022
Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2Stephanie Holm, Anna S Husted, Louise J Skov, et al.
Diabetes, Obesity & Metabolism|October 6, 2023
The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID-19 in the capital region of DenmarkVivian Kliim-Hansen, Karl S Johansson, Laerke S Gasbjerg, et al.
BMJ Open|January 31, 2023
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, et al.
European Journal of Endocrinology|April 22, 2021
Effects of endogenous GIP in patients with type 2 diabetesSigne Stensen, Lærke S Gasbjerg, Liva L Krogh, et al.
Annals of the Rheumatic Diseases|September 4, 2017
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studiesSabrina M Nielsen, Else M Bartels, Marius Henriksen, et al.
Diabetes Care|November 5, 2016
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist CircumferenceSigne Foghsgaard, Camilla Andreasen, Louise Vedtofte, et al.
Diabetologia|May 5, 2024
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank studyMarie Winther-Sørensen, Sara L Garcia, Andreas Bartholdy, et al.
Allergy|February 24, 2023
Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis-A randomized controlled studyLise Gether, Heidi Storgaard, Sanja Kezic, et al.
Diabetologia|September 29, 2017
Enteroendocrine K and L cells in healthy and type 2 diabetic individualsTina Jorsal, Nicolai A Rhee, Jens Pedersen, et al.
Pageof 46